| Treatment | No of patients analysed* | Mean change in asthma-free days, % ** (95% CI) | p Value | ||||
| Months 1–6 | |||||||
| Budesonide | 114 | +20.1 (+14.9 to +25.4) | |||||
| DSCG | 60 | +4.1 (−3.2 to +11.3) | 0.001 | ||||
| Months 7–18 | |||||||
| Bud/Bud | 55 | +29.2 (+21.2 to +37.2) | |||||
| Bud/placebo (Budesonide as needed) | 58 | +19.6 (+11.8 to +27.4) | |||||
| DSCG | 51 | +11.6 (+3.3 to +19.9) | |||||
| Bud/Bud vs Bud/placebo | 0.092 | ||||||
| Bud/Bud vs DSCG | 0.003 | ||||||
| Bud/Placebo vs DSCG | 0.166 | ||||||
*The total effective number of patients analysed; **Mean change in asthma-free days compared with the baseline.